Patients & Tumor Characteristics
Abstract
Among the breast cancer population in the institute of Nuclear Medicine, Molecular Biology and Oncology (INMO) in central Sudan, it was found that the incidence is more frequent among young women especially among those who are 40 years old or younger at presentation. Abnormal body mass index was found in the majority of the population of this study. Although gynaecological and obstetrical history was found to be insufficiently recorded in the patients folders, there was high percentage of women who had never conceived (38.2%) among those who have between 0-3 children (70%) which is known to be associated with increased risk for breast cancer . Family history of breast cancer among this group of patients (4.9%) is comparable to the internationally published figures. There was no specification mentioned on the histopathology report for tumour grade for 52% of the study population, for lymphovascular invasion for 85.3% of the study population, and for oestrogen receptor status for 86.3% of the study population, which made comment on the distribution of these important factors among the study group rather irrelevant although it appeared that high grade tumors is not infrequent among the study group. Also of note on this point that the quality of the histopathology report, which is almost always not containing the relevant information for treatment decisions and prognostication, is hindering good clinical practice and following the international management guidelines. Disease stages iiia, iiib, and vi comprised the majority of the stages among the study population and it clearly reflects the late presentation that this group of patients had.
References
1- Fisher B, Osborne C K, Margolese R, and Bloomer W. Neoplasm of Breast. Chapter XXXII: page 1711, Cancer Medicine 3rd edition. Lea and Febiger, Philadelphia, London, 1993.
2- Veronesi U, Cascinelli N , Mariani L et al. Twenty years follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. NEJM Oct 2002; 16 (347): 1227-1232.
3- Kim S H, Simkovich-Heerdt A, Tran K N et al. Women 35 years of age or younger have higher loco-regional relapse rates after undergoing breast conserving therapy.J AM Coll Surg 1998;187:1-8.
4- Feldman AL and Welch JP. Long term outcome in women less than 30 years of age with breast cancer. J Surg Oncol. 1998; 68:193-8.
5- Gajdos C, Tartter PI, Bleiweiss IJ et al. Stage 0 to stage III breast cancer in young women. J Am Coll Surg 2000; May 5 (190): 509-15.
6- Leborgne F, Leborgne JH, Ortega B et al. Breast conservation treatment of early stage breast cancer: Patterns of failure. Int J Radiat Ocol Biol Phys, 15 February 1995; 4(31): 765-775.
7- Vrieling C, Collette L, Fourquet A et al. Can patient-, treatment-, and pathology- related characteristics explain the high local recurrence rate following breast conservation therapy in young patients? European Journal of Cancer 2003 May; 7(39): 932-944.
8- Lee CG, Mc Cormick B, Mazumdar M et al. Infiltrating breast carcinoma in patient’s age 30 years and younger: Long term outcome for life relapse, and second primary tumors. Int J Radiat Oncol Bio Phys. 1992; 23: 969-975.
9- Morrow M. Breast disease in elderly women. Surg Clin North Am. 1994 Feb; 74(1): 145-61.
10- UNFPA June 2002. Breast cancer: increasing incidence, limited options ,Outlook 4 (19). 1-8.
11- WHO web site. Countries,
Sudan.http://www.who.int/countries/sdn/en.
12- Muir KR. Endocrine-disrupting pesticides and selected hormonally dependent cancers. Scand J Work Environ Health. 2005; 31 Suppl 1:55-61; discussion 5-7.
13- Safe Motherhood Survey national report- 1999. Central bureau of statistic Khartoum (CBS).
14- Amir H, et al. A comparative study of carcinoma of the breast in an African population. East Africa med J 1994 Apr; 71(4): 215-8